CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in AXSM — Axsome Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$77,372,775
+$10,589,931 QoQ
Shares Held
316,104
-20.0% QoQ
Ownership
0.603%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#32
of 500 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. AXSM ranks #22 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in AXSM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,372,775 | 316,104 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $66,782,844 | 395,118 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $73,549,128 | 402,700 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $46,399,608 | 382,047 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $37,230,797 | 356,651 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $39,333,000 | 337,246 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $27,754,956 | 328,034 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $28,991,702 | 322,596 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $24,940,349 | 309,818 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $24,025,705 | 301,074 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $23,534,842 | 295,701 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $20,259,084 | 289,871 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $19,288,230 | 268,414 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $15,365,598 | 249,118 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $19,264,760 | 249,770 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,099,870 | 226,353 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,207,153 | 214,286 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,824,886 | 213,213 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,829,149 | 207,230 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,725,553 | 204,052 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $12,553,968 | 186,095 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,352,514 | 182,842 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $14,441,942 | 177,267 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $12,498,176 | 175,413 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $14,895,971 | 181,040 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $9,873,438 | 167,830 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||